Yeh SP - Search Results

1

A Phase II Study of Arginine Deiminase (ADI-PEG20) in Relapsed/Refractory or Poor-Risk Acute Myeloid Leukemia Patients.

Tsai HJ, Jiang SS, Hung WC, Borthakur G, Lin SF, Pemmaraju N, Jabbour E, Bomalaski JS, Chen YP, Hsiao HH, Wang MC, Kuo CY, Chang H, Yeh SP, Cortes J, Chen LT, Chen TY. Tsai HJ, et al. Among authors: yeh sp. Sci Rep. 2017 Sep 12;7(1):11253. doi: 10.1038/s41598-017-10542-4. Sci Rep. 2017. PMID: 28900115 Free PMC article. Clinical Trial.

2

Prognostic impact of allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia patients with internal tandem duplication of FLT3.

Lin PH, Lin CC, Yang HI, Li LY, Bai LY, Chiu CF, Liao YM, Lin CY, Hsieh CY, Lin CY, Ho CM, Yang SF, Peng CT, Tsai FJ, Yeh SP. Lin PH, et al. Among authors: yeh sp. Leuk Res. 2013 Mar;37(3):287-92. doi: 10.1016/j.leukres.2012.10.005. Epub 2012 Dec 29. Leuk Res. 2013. PMID: 23276395

3

The oncometabolite R-2-hydroxyglutarate activates NF-κB-dependent tumor-promoting stromal niche for acute myeloid leukemia cells.

Chen JY, Lai YS, Tsai HJ, Kuo CC, Yen BL, Yeh SP, Sun HS, Hung WC. Chen JY, et al. Among authors: yeh sp. Sci Rep. 2016 Aug 31;6:32428. doi: 10.1038/srep32428. Sci Rep. 2016. PMID: 27577048 Free PMC article.

4

A noninterventional observational registry of patients with multiple myeloma treated with lenalidomide in Taiwan.

Huang SY, Yu YB, Yeh SP, Chen TY, Kao WY, Chen CC, Wang MC, Lin HY, Lin SF, Lin TH, Hua Y, Puccio-Pick M, DeMarco D, Jacques C, Dunn P. Huang SY, et al. Among authors: yeh sp. J Formos Med Assoc. 2017 Sep;116(9):705-710. doi: 10.1016/j.jfma.2016.11.005. Epub 2016 Dec 21. J Formos Med Assoc. 2017. PMID: 28012677 Free article.

5

Efficacy, safety, and pharmacokinetics of subcutaneous azacitidine in Taiwanese patients with higher-risk myelodysplastic syndromes.

Chou WC, Yeh SP, Hsiao LT, Lin SF, Chen YC, Chen TY, Laille E, Galettis A, Dong Q, Songer S, Beach CL. Chou WC, et al. Among authors: yeh sp. Asia Pac J Clin Oncol. 2017 Oct;13(5):e430-e439. doi: 10.1111/ajco.12659. Epub 2017 Jan 25. Asia Pac J Clin Oncol. 2017. PMID: 28124500

6

Stem cell transplantation for T-cell lymphomas in Taiwan.

Hsu YT, Tsai HJ, Chang JS, Li SS, Tang JL, Yeh SP, Hwang WL, Liu JH, Tan TD, Wang PN, Hsiao HH, Chen TY. Hsu YT, et al. Among authors: yeh sp. Bone Marrow Transplant. 2018 Aug;53(8):993-1000. doi: 10.1038/s41409-018-0116-6. Epub 2018 Feb 12. Bone Marrow Transplant. 2018. PMID: 29434288

7

Epidemiology and risk factors for invasive fungal infections during induction chemotherapy for newly diagnosed acute myeloid leukemia: A retrospective cohort study.

Lien MY, Chou CH, Lin CC, Bai LY, Chiu CF, Yeh SP, Ho MW. Lien MY, et al. Among authors: yeh sp. PLoS One. 2018 Jun 8;13(6):e0197851. doi: 10.1371/journal.pone.0197851. eCollection 2018. PLoS One. 2018. PMID: 29883443 Free PMC article.

8

Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial.

Horwitz S, O'Connor OA, Pro B, Illidge T, Fanale M, Advani R, Bartlett NL, Christensen JH, Morschhauser F, Domingo-Domenech E, Rossi G, Kim WS, Feldman T, Lennard A, Belada D, Illés Á, Tobinai K, Tsukasaki K, Yeh SP, Shustov A, Hüttmann A, Savage KJ, Yuen S, Iyer S, Zinzani PL, Hua Z, Little M, Rao S, Woolery J, Manley T, Trümper L; ECHELON-2 Study Group. Horwitz S, et al. Among authors: yeh sp. Lancet. 2019 Jan 19;393(10168):229-240. doi: 10.1016/S0140-6736(18)32984-2. Epub 2018 Dec 4. Lancet. 2019. PMID: 30522922 Free PMC article. Clinical Trial.

9

Long-term safety and efficacy of deferasirox in patients with myelodysplastic syndrome, aplastic anemia and other rare anemia in Taiwan.

Ko BS, Chang MC, Chiou TJ, Chang TK, Chen YC, Lin SF, Chang CS, Lu YC, Yeh SP, Chen TY, Hwang WS. Ko BS, et al. Among authors: yeh sp. Hematology. 2019 Dec;24(1):247-254. doi: 10.1080/16078454.2018.1557860. Hematology. 2019. PMID: 30558522 Free article. Clinical Trial.

10

Safety and efficacy of talacotuzumab plus decitabine or decitabine alone in patients with acute myeloid leukemia not eligible for chemotherapy: results from a multicenter, randomized, phase 2/3 study.

Montesinos P, Roboz GJ, Bulabois CE, Subklewe M, Platzbecker U, Ofran Y, Papayannidis C, Wierzbowska A, Shin HJ, Doronin V, Deneberg S, Yeh SP, Ozcan MA, Knapper S, Cortes J, Pollyea DA, Ossenkoppele G, Giralt S, Döhner H, Heuser M, Xiu L, Singh I, Huang F, Larsen JS, Wei AH. Montesinos P, et al. Among authors: yeh sp. Leukemia. 2021 Jan;35(1):62-74. doi: 10.1038/s41375-020-0773-5. Epub 2020 Mar 16. Leukemia. 2021. PMID: 32203138 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

154 results

Search Page

Filters